Genotoxicity testing is crucial for medical device safety. Labcorp's chromosomal aberration assay meticulously evaluates chromosomes to determine if a device causes genotoxic harm. This powerful tool assesses potential risks early in development, enabling manufacturers to mitigate risks before commercialization. The scientists at the GeneTox Laboratory in Bedford, Massachusetts, understand the intricacies of this test and offer it to sponsors for the evaluation of their medical devices, one chromosome at a time.

• Download